Status:

UNKNOWN

Rheumatoid Arthritis-Associated Interstitial Lung Disease: Characterization of Lung Disease Progression

Lead Sponsor:

Hospital do Coracao

Collaborating Sponsors:

Bristol-Myers Squibb

Boehringer Ingelheim

Conditions:

Rheumatoid Lung

Rheumatoid Arthritis

Eligibility:

All Genders

18+ years

Brief Summary

BERTHA study´s primary objective is to characterize Rheumatoid Arthritis-associated Interstitial Lung Disease (RA-ILD) progression and to define a combination of biomarkers, genetic and clinical varia...

Detailed Description

BERTHA is a multicentric, observational study that will enroll 100 RA-ILD patients to be followed for 2 years. Interstitial Lung Disease (ILD) progression will be ascertained by quantitative image an...

Eligibility Criteria

Inclusion

  • Consecutive adult patients (aged \>18 years) meeting RA diagnostic criteria in accordance with ACR 2010
  • Presence of interstitial lung disease 2.1 ILD Definition: presence of interstitial alterations in HRCT associated to functional derangements and/or symptoms
  • Patient agrees with having follow-up visits every 6 months for 2 years

Exclusion

  • Pregnancy or intending to become pregnant
  • Overlap with other diseases that occurs with ILD (other collagenoses, vasculitis, inflammatory bowel disease)
  • Presence of advanced ILD, characterized by:
  • a. Dyspnea rated as modified Medical Research Council 4 (mMRC4) on routine visit
  • Presence of significant Arterial Pulmonary Hypertension:
  • Evidence of Right ventricular failure evidence by echocardiography
  • Previous right chamber catheterism showing cardiac index \< 2 liters/min/m²
  • Significant co-morbidity impacting respiratory system (e.g., congestive heart failure, lung neoplasm, active tuberculosis)

Key Trial Info

Start Date :

March 1 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

May 31 2024

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT04136223

Start Date

March 1 2021

End Date

May 31 2024

Last Update

June 29 2023

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Hospital Universitário de Brasilia (HUB)

Brasília, Federal District, Brazil, 70840-901

2

Hospital das Clinicas - FMUSP

São Paulo, São Paulo, Brazil, 05403-000

3

Universidade Estadual de Campinas (UNICAMP)

Campinas, Brazil

4

LABOX - Federal University of Santa Catarina (UFSC)

Florianópolis, Brazil